TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $143,739,000 | +32.8% | 1,910,170 | -52.6% | 0.03% | +52.6% |
| Q1 2022 | $108,231,000 | -43.4% | 4,030,991 | +0.5% | 0.02% | -38.7% |
| Q4 2021 | $191,261,000 | -15.5% | 4,009,654 | +17.7% | 0.03% | -18.4% |
| Q3 2021 | $226,357,000 | -15.9% | 3,407,475 | -1.2% | 0.04% | -15.6% |
| Q2 2021 | $269,155,000 | +35.4% | 3,449,809 | +64.1% | 0.04% | +28.6% |
| Q1 2021 | $198,813,000 | -27.0% | 2,101,844 | -5.9% | 0.04% | -30.0% |
| Q4 2020 | $272,182,000 | +40.9% | 2,233,745 | +1.0% | 0.05% | +25.0% |
| Q3 2020 | $193,203,000 | +31.0% | 2,211,571 | -3.2% | 0.04% | +21.2% |
| Q2 2020 | $147,515,000 | +113.1% | 2,283,872 | +47.3% | 0.03% | +83.3% |
| Q1 2020 | $69,224,000 | – | 1,550,015 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |